Controlled-Release Oxycodone and Naloxone in the Treatment of Chronic Low Back Pain: A Placebo-Controlled, Randomized Study
Author(s) -
Christian Cloutier,
J Taliano,
William O’Mahony,
M Csanadi,
Gal Cohen,
Ian Sutton,
Donald M. Sinclair,
M Awde,
Sam Henein,
Lawrence R. Robinson,
John Eisenhoffer,
PS Piraino,
Zoltan Harsanyi,
KJ Michalko
Publication year - 2013
Publication title -
pain research and management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.702
H-Index - 56
eISSN - 1918-1523
pISSN - 1203-6765
DOI - 10.1155/2013/164609
Subject(s) - oxycodone , placebo , medicine , tolerability , anesthesia , opioid , analgesic , (+) naloxone , randomized controlled trial , population , adverse effect , environmental health , alternative medicine , receptor , pathology
For Canadian regulatory purposes, an analgesic study was required to complement previously completed, pivotal studies on bowel effects and analgesia associated with controlled-release (CR) oxycodone⁄CR naloxone.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom